Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Few & Far Between: Conversations from the Front Lines of Drug Development

Sep 20 2023 | 00:26:33

00:00 / 00:26:33

Show Notes

Episode Transcript

"Having come from the clinical trial side, I then went to the management side. So, I understood all the problems that occur or arise when a clinical trial is being conducted - knowing what to watch out for, why the protocol is written the way it is. So that was an immense help." - Dr. Diana Sims-Silbermann Biorasi CEO, Chris O'Brien, welcomes Dr. Diana Sims-Silbermann to the latest episode of the Few & Far Between podcast. In her previous roles as a clinician and Senior Trial Manager for Janssen Pharmaceuticals, Dr. Sims-Silbermann has remained an inquisitive observer and skilled facilitator for clinical studies in Europe, with a keen understanding of regulatory requirements and patient centricity.

Other Episodes

Episode 32

August 17, 2023 • 00:37:05

Episode 32: Stephanie Wisner, Author, Co-Founder at Centivax

"In research or in biotech, time is expensive. Time is the most expensive thing that you have." - Stephanie Wisner, Author, Co-Founder at Centivax...

Episode 9

September 01, 2021 • 00:47:27

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael...

Episode 34

October 10, 2023 • 00:44:45

Episode 34: Dan Mandell, CEO at GRO Biosciences

"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....